SEC Form 4 · accession 0001140361-18-018958
NRC HEALTH · NRC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael D. Hays
Officer — CEO · Director
Period of report
Apr 17, 2018
Accepted (ET)
Apr 18, 2018 · 5:44 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000070487
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class B Common StockF1,F2 | Apr 17, 2018 | D | 125 | — | D | 0 | I | By Spouse |
| Common StockF1,F2 | Apr 17, 2018 | A | 125 | — | A | 139,095 | I | By Spouse |
| Class B Common StockF1,F2 | Apr 17, 2018 | D | 12 | — | D | 0 | I | By Spouse & Daughter Jt |
| Common StockF1,F2 | Apr 17, 2018 | A | 12 | — | A | 87 | I | By Spouse & Daughter Jt |
| Common StockF1,F3 | Apr 17, 2018 | A | 3,870 | — | A | 3,870 | D | |
| Common Stock | Apr 17, 2018 | F | 1,799 | $33.55 | D | 2,071 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F3 | $21.50 | Apr 17, 2018 | D | 2,491 | D | — | Jan 5, 2022 | Class B Common Stock | 2,491 | 0 | D |
| Employee Stock Option (right to buy)F3 | $27.13 | Apr 17, 2018 | D | 1,823 | D | — | Jan 7, 2023 | Class B Common Stock | 1,823 | 0 | D |
| Employee Stock Option (right to buy)F3 | $34.15 | Apr 17, 2018 | D | 266 | D | — | Jan 7, 2024 | Class B Common Stock | 266 | 0 | D |
| Employee Stock Option (right to buy)F3 | $35.48 | Apr 17, 2018 | D | 1,669 | D | — | Jan 6, 2025 | Class B Common Stock | 1,669 | 0 | D |
| Employee Stock Option (right to buy)F3 | $34.00 | Apr 17, 2018 | D | 1,524 | D | — | Jan 5, 2026 | Class B Common Stock | 1,524 | 0 | D |
| Employee Stock Option (right to buy)F3 | $40.54 | Apr 17, 2018 | D | 1,246 | D | — | Jan 4, 2027 | Class B Common Stock | 1,246 | 0 | D |
| Employee Stock Option (right to buy)F4 | $8.12 | holding | — | — | — | — | Jan 5, 2019 | Common Stock | 20,109 | 20,109 | D |
| Employee Stock Option (right to buy)F5 | $6.29 | holding | — | — | — | — | Jan 5, 2020 | Common Stock | 26,481 | 26,481 | D |
| Employee Stock Option (right to buy)F6 | $9.14 | holding | — | — | — | — | Jan 5, 2021 | Common Stock | 17,745 | 17,745 | D |
| Employee Stock Option (right to buy)F7 | $10.75 | holding | — | — | — | — | Jan 5, 2022 | Common Stock | 14,949 | 14,949 | D |
| Employee Stock Option (right to buy)F8 | $14.50 | holding | — | — | — | — | Jan 7, 2023 | Common Stock | 10,938 | 10,938 | D |
| Employee Stock Option (right to buy)F9 | $18.80 | holding | — | — | — | — | Jan 7, 2024 | Common Stock | 2,904 | 2,904 | D |
| Employee Stock Option (right to buy)F10 | $13.17 | holding | — | — | — | — | Jan 6, 2025 | Common Stock | 10,014 | 10,014 | D |
| Employee Stock Option (right to buy)F11 | $15.23 | holding | — | — | — | — | Jan 5, 2026 | Common Stock | 9,145 | 9,145 | D |
| Employee Stock Option (right to buy)F12 | $18.80 | holding | — | — | — | — | Jan 4, 2027 | Common Stock | 7,478 | 7,478 | D |
| Employee Stock Option (right to buy)F13 | $36.80 | holding | — | — | — | — | Jan 3, 2028 | Common Stock | 5,193 | 5,193 | D |
Explanation of responses
- F1On April 17, 2018, the Issuer completed a recapitalization whereby the Issuer exchanged one share of its then-existing class A common stock, plus $19.59 in cash, without interest, for each share of its then-existing class B common stock and, following such exchange, each share of class A common stock was reclassified as a share of Common Stock (the "Recapitalization").
- F10This option becomes fully exercisable on January 6, 2020.
- F11This option becomes fully exercisable on January 5, 2021.
- F12This option becomes fully exercisable on January 4, 2022.
- F13This option becomes fully exercisable on January 3, 2023.
- F2The reporting person disclaims beneficial ownership of these shares.
- F3Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash, for each class B option, less the exercise price per share of the option and any applicable tax withholding.
- F4This option became fully exercisable on January 5, 2014.
- F5This option became fully exercisable on January 5, 2015.
- F6This option became fully exercisable on January 5, 2016.
- F7This option became fully exercisable on January 5, 2017.
- F8This option became fully exercisable on January 7, 2018.
- F9This option becomes fully exercisable on January 7, 2019.